List of Excipients in API MEXILETINE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing MEXILETINE HYDROCHLORIDE
Detailed excipient profiles for MEXILETINE HYDROCHLORIDE
Excipient focus: ALCOHOL
MEXILETINE HYDROCHLORIDE drug variants containing ALCOHOL
MEXILETINE HYDROCHLORIDE drug variants not containing ALCOHOL
Excipient focus: AMMONIA
MEXILETINE HYDROCHLORIDE drug variants containing AMMONIA
MEXILETINE HYDROCHLORIDE drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
MEXILETINE HYDROCHLORIDE drug variants containing BUTYL ALCOHOL
MEXILETINE HYDROCHLORIDE drug variants not containing BUTYL ALCOHOL
Excipient focus: D&C RED NO. 28
MEXILETINE HYDROCHLORIDE drug variants containing D&C RED NO. 28
MEXILETINE HYDROCHLORIDE drug variants not containing D&C RED NO. 28
Excipient focus: D&C YELLOW NO. 10
MEXILETINE HYDROCHLORIDE drug variants containing D&C YELLOW NO. 10
MEXILETINE HYDROCHLORIDE drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C BLUE NO. 1
MEXILETINE HYDROCHLORIDE drug variants containing FD&C BLUE NO. 1
MEXILETINE HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
MEXILETINE HYDROCHLORIDE drug variants containing FD&C BLUE NO. 2
MEXILETINE HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 3
MEXILETINE HYDROCHLORIDE drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | mexiletine hydrochloride | 63629-1964 |
| Bryant Ranch Prepack | mexiletine hydrochloride | 72162-1774 |
| >Company | >Ingredient | >NDC |
MEXILETINE HYDROCHLORIDE drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
MEXILETINE HYDROCHLORIDE drug variants containing FD&C RED NO. 40
MEXILETINE HYDROCHLORIDE drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
MEXILETINE HYDROCHLORIDE drug variants containing FD&C YELLOW NO. 6
MEXILETINE HYDROCHLORIDE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
MEXILETINE HYDROCHLORIDE drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | mexiletine hydrochloride | 0527-4107 |
| >Company | >Ingredient | >NDC |
MEXILETINE HYDROCHLORIDE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
MEXILETINE HYDROCHLORIDE drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | mexiletine hydrochloride | 0527-4107 |
| >Company | >Ingredient | >NDC |
MEXILETINE HYDROCHLORIDE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
MEXILETINE HYDROCHLORIDE drug variants containing FERROSOFERRIC OXIDE
MEXILETINE HYDROCHLORIDE drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | mexiletine hydrochloride | 63629-1963 |
| Bryant Ranch Prepack | mexiletine hydrochloride | 63629-1964 |
| Bryant Ranch Prepack | mexiletine hydrochloride | 72162-1773 |
| Bryant Ranch Prepack | mexiletine hydrochloride | 72162-1774 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
MEXILETINE HYDROCHLORIDE drug variants containing GELATIN
MEXILETINE HYDROCHLORIDE drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
MEXILETINE HYDROCHLORIDE drug variants containing ISOPROPYL ALCOHOL
MEXILETINE HYDROCHLORIDE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: MAGNESIUM PALMITOSTEARATE
MEXILETINE HYDROCHLORIDE drug variants containing MAGNESIUM PALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | mexiletine hydrochloride | 0527-4107 |
| Chartwell RX LLC | mexiletine hydrochloride | 62135-785 |
| >Company | >Ingredient | >NDC |
MEXILETINE HYDROCHLORIDE drug variants not containing MAGNESIUM PALMITOSTEARATE
Excipient focus: MAGNESIUM STEARATE
MEXILETINE HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE
MEXILETINE HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | mexiletine hydrochloride | 0527-4107 |
| Chartwell RX LLC | mexiletine hydrochloride | 62135-785 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
MEXILETINE HYDROCHLORIDE drug variants containing MICROCRYSTALLINE CELLULOSE 101
MEXILETINE HYDROCHLORIDE drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: POTASSIUM HYDROXIDE
MEXILETINE HYDROCHLORIDE drug variants containing POTASSIUM HYDROXIDE
MEXILETINE HYDROCHLORIDE drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: PROPYLENE GLYCOL
MEXILETINE HYDROCHLORIDE drug variants containing PROPYLENE GLYCOL
MEXILETINE HYDROCHLORIDE drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
MEXILETINE HYDROCHLORIDE drug variants containing SHELLAC
MEXILETINE HYDROCHLORIDE drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
MEXILETINE HYDROCHLORIDE drug variants containing SILICON DIOXIDE
MEXILETINE HYDROCHLORIDE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
MEXILETINE HYDROCHLORIDE drug variants containing STARCH, CORN
MEXILETINE HYDROCHLORIDE drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
MEXILETINE HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE
MEXILETINE HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
